These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6763209)

  • 1. Design and interpretation of clinical trials of long-acting analgesics.
    Neidert GL
    Pharmacotherapy; 1982; 2(5):285-6. PubMed ID: 6763209
    [No Abstract]   [Full Text] [Related]  

  • 2. Challenges in analgesic drug development.
    Hewitt DJ; Hargreaves RJ; Curtis SP; Michelson D
    Clin Pharmacol Ther; 2009 Oct; 86(4):447-50. PubMed ID: 19675542
    [No Abstract]   [Full Text] [Related]  

  • 3. An open study of botulinum-A toxin treatment of trigeminal neuralgia.
    Zakrzewska JM; Cohen J; Brown J; Alksne J; Gemillion H; Linskey M; Sirois D; Pollock B
    Neurology; 2006 May; 66(9):1458-9; author reply 1458-9. PubMed ID: 16685762
    [No Abstract]   [Full Text] [Related]  

  • 4. Open label extension studies and the ethical design of clinical trials.
    Casarett D; Karlawish J; Sankar P; Hirschman KB; Asch DA
    IRB; 2001; 23(4):1-5. PubMed ID: 11837283
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical trials of drugs. Special features of clinical studies of analgesics and psychotropic drugs].
    Hennemann A
    Med Monatsschr Pharm; 2003 Jul; 26(7):224-6. PubMed ID: 12879619
    [No Abstract]   [Full Text] [Related]  

  • 6. Deceptive research.
    Miller FG
    Arch Gen Psychiatry; 2008 Oct; 65(10):1225-6; author reply 1226. PubMed ID: 18838641
    [No Abstract]   [Full Text] [Related]  

  • 7. A primer on the design, conduct, and interpretation of clinical trials.
    Appel LJ
    Clin J Am Soc Nephrol; 2006 Nov; 1(6):1360-7. PubMed ID: 17699370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical study of antalgic drugs].
    Dubray C
    Therapie; 1999; 54(1):135-45. PubMed ID: 10216437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Individual responder analyses for pain: does one dose fit all?
    Mather LE
    Trends Pharmacol Sci; 2005 Nov; 26(11):544-5. PubMed ID: 16165226
    [No Abstract]   [Full Text] [Related]  

  • 10. What can we learn from failed neuropathic pain trials?
    Polydefkis M; Raja SN
    Neurology; 2008 Jan; 70(4):250-1. PubMed ID: 18209199
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical trials in rheumatology: asking the relevant question.
    Weintraub M
    J Rheumatol; 1979; 6(4):365-9. PubMed ID: 522090
    [No Abstract]   [Full Text] [Related]  

  • 12. Five easy pieces on evidence-based medicine (4).
    Kalso E; Edwards J; McQuay HJ; Moore RA
    Eur J Pain; 2002; 6(1):89-93. PubMed ID: 11888232
    [No Abstract]   [Full Text] [Related]  

  • 13. An audience with Robert Dworkin. Interview by Asher Mullard.
    Dworkin R
    Nat Rev Drug Discov; 2011 Aug; 10(8):570. PubMed ID: 21804588
    [No Abstract]   [Full Text] [Related]  

  • 14. Designing clinical trials for NOTES.
    Romagnuolo J; Cotton P
    Gastrointest Endosc Clin N Am; 2008 Apr; 18(2):371-85; xi. PubMed ID: 18381177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Drug research by the family physician in general and particularly of the analgetic diflunisal].
    Offerhaus L
    Ned Tijdschr Geneeskd; 1980 Apr; 124(14):516-9. PubMed ID: 7374814
    [No Abstract]   [Full Text] [Related]  

  • 16. A 25-year review of sequential methodology in clinical studies.
    Todd S
    Stat Med; 2007 Jan; 26(2):237-52. PubMed ID: 17139691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [How to improve the quality of clinical trials].
    Galende I; Sacristán JA; Soto J
    Med Clin (Barc); 1994 Apr; 102(12):465-70. PubMed ID: 8207997
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical trial outcome in neuropathic pain: relationship to study characteristics.
    Katz J; Finnerup NB; Dworkin RH
    Neurology; 2008 Jan; 70(4):263-72. PubMed ID: 17914067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re: Design and endpoints of clinical trials in hepatocellular carcinoma.
    Di Maio M; Daniele B; Gallo C; Perrone F
    J Natl Cancer Inst; 2008 Nov; 100(21):1557; author reply 1557-8. PubMed ID: 18957679
    [No Abstract]   [Full Text] [Related]  

  • 20. What should be the role of homogeneity testing in adaptive trials?
    Gallo P; Chuang-Stein C
    Pharm Stat; 2009; 8(1):1-4. PubMed ID: 18642402
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.